ArticleWorld journal of microbiology & biotechnology2026
Whole genome investigation of multi-drug resistant Staphylococcus aureus strain.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of multidrug-resistant (MDR) Staphylococcus aureus strains poses significant challenges for effective management and treatment, often harboring genes associated with antimicrobial resistance (AMR) and virulence factors contributing to their pathogenicity, establishing them as a global health threat. This study aims to perform a comprehensive genomic investigation of a Libyan MDR S. aureus strain to assess its resistance profile and virulence mechanisms. Whole genome sequencing and bioinformatics analyses, including comparative genome analysis, phylogenetics and the screening of key genetic elements involved in pathogenicity and AMR, were conducted to explore the genomic features of this strain. Several resistance detection tools and databases were applied to evaluate variations in genomic annotation and prediction. Our strain presented a 2.77 Mb genome with 2,650 coding sequences, sharing 94.04% orthologous genes with the CC239-MRSA-III strain. Key resistance and virulence factors, such as mecA, blaZ, and efflux pumps, were identified, along with point mutations in metabolic and replication enzymes. Additionally, an alanine racemase gene (alr) homologous to the vanT in vanG cluster was identified, suggesting a potential evolving resistance variant and pointing to a potential under-characterized gene related to early stages of resistance development. Variations among resistance prediction tools also highlighted the need for integrating multiple analysis approaches. This study provides a detailed genomic analysis of a Libyan MDR S. aureus strain, revealing an extensive array of resistance and virulence factors. The discrepancies across resistance detection tools underscore the importance of standardized genomic investigation approaches for improved management of resistant infections.
Indexed as
Identifiers
41803382What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.